ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 184 filers reported holding ALKERMES PLC in Q2 2013. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $562,000 | -64.6% | 25,148 | -61.1% | 0.08% | -57.9% |
Q2 2021 | $1,586,000 | +23.7% | 64,673 | -5.8% | 0.18% | -16.4% |
Q1 2021 | $1,282,000 | -27.3% | 68,619 | -35.5% | 0.21% | -27.6% |
Q3 2020 | $1,763,000 | -3.2% | 106,427 | +19.1% | 0.29% | +38.7% |
Q4 2019 | $1,822,000 | +379.5% | 89,331 | +358.4% | 0.21% | +315.7% |
Q3 2019 | $380,000 | -39.7% | 19,489 | -30.3% | 0.05% | -28.2% |
Q2 2019 | $630,000 | +19.8% | 27,970 | +57.0% | 0.07% | +16.4% |
Q4 2018 | $526,000 | -0.4% | 17,810 | +97.9% | 0.06% | +134.6% |
Q3 2015 | $528,000 | -46.5% | 9,000 | -41.3% | 0.03% | -31.6% |
Q2 2015 | $986,000 | -86.2% | 15,329 | -86.9% | 0.04% | -86.6% |
Q1 2015 | $7,137,000 | +3450.7% | 117,064 | +2403.0% | 0.28% | +2481.8% |
Q3 2014 | $201,000 | -56.6% | 4,677 | -55.5% | 0.01% | -66.7% |
Q1 2014 | $463,000 | -60.6% | 10,510 | -74.4% | 0.03% | -76.3% |
Q2 2013 | $1,175,000 | – | 40,981 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |